. Real-world experience with continuous subcutaneous foslevodopa/foscarbidopa infusion: insights and recommendations. J Neural Transm (Vienna). 2025 Mar 22; Epub 2025 Mar 22 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

AlzAntibodiesAlzBiomarkerAlzRiskBrain BanksGeneticsAlzGeneHEXMutationsProtocolsResearch ModelsTherapeutics